Cite
NEURONAL ANTIBODIES IN PAEDIATRIC EPILEPSY: CLINICAL FEATURES AND LONG-TERM OUTCOMES
MLA
Wright, S., et al. Neuronal Antibodies in Paediatric Epilepsy: Clinical Features and Long-Term Outcomes. Feb. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..f8623271329d84f0ecfe9d5fe179e107&authtype=sso&custid=ns315887.
APA
Wright, S., Geerts, A. T., Jol-van Der Zijde, C. M., Jacobson, L., Lang, B., Waters, P., Tol, M. J. D. van, Stroink, H., Neuteboom, R. F., Brouwer, O. F., & Vincent, A. (2015). Neuronal Antibodies in Paediatric Epilepsy: Clinical Features and Long-Term Outcomes.
Chicago
Wright, S., A.T. Geerts, C.M. Jol-van Der Zijde, L. Jacobson, B. Lang, P. Waters, M.J.D. van Tol, et al. 2015. “Neuronal Antibodies in Paediatric Epilepsy: Clinical Features and Long-Term Outcomes,” February. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..f8623271329d84f0ecfe9d5fe179e107&authtype=sso&custid=ns315887.